SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001010412-11-000460
Filing Date
2011-08-15
Accepted
2011-08-15 14:31:29
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ON FORM 10Q FOR THE QUARTER ENDED JUNE 30, 2011 sanguineform10qjune112.htm 10-Q 202577
2 WHARTON NOTE whartonnote_final.htm EX-10 50784
3 302 CERTIFICATION OF CEO ex311.htm EX-31 6474
4 302 CERTIFICATION OF CFO ex312.htm EX-31 6451
5 906 CERTIFICATION ex32.htm EX-32 4348
  Complete submission text file 0001010412-11-000460.txt   1392828

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sgnc-20110630.xml EX-101.INS 152637
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgnc-20110630_pre.xml EX-101.PRE 63042
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgnc-20110630_lab.xml EX-101.LAB 85497
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sgnc-20110630_def.xml EX-101.DEF 50074
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sgnc-20110630_cal.xml EX-101.CAL 32045
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgnc-20110630.xsd EX-101.SCH 10545
Mailing Address 110 FOUNDERS MILL COURT ROSWELL GA 30075
Business Address 110 FOUNDERS MILL COURT ROSWELL GA 30075 678-352-9060
SANGUINE CORP (Filer) CIK: 0000926287 (see all company filings)

IRS No.: 954347608 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24480 | Film No.: 111035272
SIC: 2835 In Vitro & In Vivo Diagnostic Substances